{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:55:05Z","timestamp":1789833305361,"version":"4.0.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T00:00:00Z","timestamp":1311120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022074","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T20:53:56Z","timestamp":1311195236000},"page":"e22074","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Polyantigenic Interferon-\u03b3 Responses Are Associated with Protection from TB among HIV-Infected Adults with Childhood BCG Immunization"],"prefix":"10.1371","volume":"6","clinical-trial-number":[{"clinical-trial-number":"nct0052195","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Timothy","family":"Lahey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Arbeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mecky","family":"Matee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Robert","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Mtei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni M.","family":"Vuola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisali","family":"Pallangyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Fordham","family":"von Reyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"ref1","first-page":"255","article-title":"Protective vaccination against tuberculosis with special reference to BCG vaccination.","volume":"58","author":"J Aronson","year":"1948","journal-title":"Am Rev Tuberc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0041-3879(49)80055-9","article-title":"BCG vaccination of infant Indians in Saskatchewan.","volume":"30","author":"R Ferguson","year":"1949","journal-title":"Tubercle"},{"key":"ref3","first-page":"690","article-title":"BCG vaccination in tuberculous households.","volume":"84","author":"S Rosenthal","year":"1960","journal-title":"Am Rev Respir Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.","volume":"359","author":"GF Black","year":"2002","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.","volume":"271","author":"GA Colditz","year":"1994","journal-title":"Jama"},{"key":"ref6","first-page":"29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.","volume":"96","author":"GA Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"ref7","first-page":"56","article-title":"Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Research Centre (ICMR), Chennai.","volume":"110","year":"1999","journal-title":"Indian J Med Res"},{"key":"ref8","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"JA Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study.","volume":"291","author":"NE Aronson","year":"2004","journal-title":"Jama"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/341901","article-title":"New vaccines for the prevention of tuberculosis.","volume":"35","author":"CF von Reyn","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)61036-3","article-title":"Tuberculosis vaccine development: goals, immunological design, and evaluation.","volume":"372","author":"DF Hoft","year":"2008","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis.","volume":"375","author":"SH Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.","volume":"24","author":"CF von Reyn","year":"2010","journal-title":"Aids"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","article-title":"Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.","volume":"72","author":"AW Olsen","year":"2004","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/00365540802032759","article-title":"Rational design of novel antibacterial vaccines with an emphasis on tuberculosis.","volume":"40","author":"SH Kaufmann","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"ref16","first-page":"69","article-title":"The occurrence of tuberculosis in persons who failed to react to tuberculin, and in persons with positive tuberculin reactions.","volume":"30","author":"EW Flahiff","year":"1939","journal-title":"Am Jour Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0041-3879(85)90077-7","article-title":"Exogenous reinfection in experimental airborne tuberculosis.","volume":"66","author":"JE Ziegler","year":"1985","journal-title":"Tubercle"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.1968.tb16704.x","article-title":"Identification of the tuberculous-infected by skin tests.","volume":"154","author":"LB Edwards","year":"1968","journal-title":"Ann NY Acad Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity.","volume":"346","author":"PEM Fine","year":"1995","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.","volume":"2","author":"PD Hart","year":"1977","journal-title":"Brit Med J"},{"key":"ref21","first-page":"155","article-title":"Protective inoculation against human tuberculosis with heat-killed tubercle bacilli.","volume":"29","author":"EL Opie","year":"1939","journal-title":"Am J Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1164\/arrd.1959.80.5.676","article-title":"Vaccination against tuberculosis with non-living vaccines. I. The problem and its historical background.","volume":"80","author":"DW Weiss","year":"1959","journal-title":"Am Rev Respir Dis"},{"key":"ref23","first-page":"255","article-title":"Protective vaccination against tuberculosis with special reference to BCG vaccination.","volume":"58","author":"JD Aronson","year":"1948","journal-title":"Am Rev Tuberc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0041-3879(49)80055-9","article-title":"BCG vaccination of infant Indians in Saskatchewan.","volume":"30","author":"RG Ferguson","year":"1949","journal-title":"Tubercle"},{"key":"ref25","first-page":"690","article-title":"BCG vaccination in tuberculous households.","volume":"84","author":"SR Rosenthal","year":"1960","journal-title":"Am Rev Respir Dis"},{"key":"ref26","first-page":"622","article-title":"BCG vaccination against tuberculosis in Chicago: a twenty year study statistically analyzed.","volume":"28","author":"SR Rosenthal","year":"1961","journal-title":"Pediatrics"},{"key":"ref27","first-page":"517","article-title":"Results of BCG immunization in New York City. Am Rev Tuberc. 1948;53:517-32.","volume":"53","author":"MI Levine","year":"1948","journal-title":"Am Rev Tuberc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/656332","article-title":"Interferon gamma responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.","volume":"202","author":"T Lahey","year":"2010","journal-title":"The Journal of infectious diseases"},{"key":"ref29","first-page":"1037","article-title":"Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania.","volume":"12","author":"PJ Munseri","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","article-title":"Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.","volume":"177","author":"R Diel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/infdis\/174.1.113","article-title":"Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guerin.","volume":"174","author":"EB Kemp","year":"1996","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-9-21","article-title":"Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.","volume":"9","author":"T Lahey","year":"2009","journal-title":"BMC Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4049\/jimmunol.165.3.1479","article-title":"Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community.","volume":"165","author":"SK Schwander","year":"2000","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1086\/313887","article-title":"In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guerin.","volume":"30","author":"S Worku","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.","volume":"320","author":"PA Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"ref36","article-title":"Statement on Medical Ethics in the Event of Disaster.","author":"WM Association","year":"2006"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1462-5822.2003.00351.x","article-title":"Mycobacterium tuberculosis cell envelope lipids and the host immune response.","volume":"6","author":"PC Karakousis","year":"2004","journal-title":"Cell Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.17.1.297","article-title":"The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.","volume":"17","author":"SA Porcelli","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrmicro1773","article-title":"Type VII secretion--mycobacteria show the way.","volume":"5","author":"AM Abdallah","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection.","volume":"335","author":"E Jouanguy","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4161\/hv.6.4.10711","article-title":"Towards new tuberculosis vaccines.","volume":"6","author":"S Svenson","year":"2010","journal-title":"Human vaccines"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/651489","article-title":"Update on research and development pipeline: tuberculosis vaccines.","volume":"50","author":"B Beresford","year":"2010","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/JVI.78.3.1160-1168.2004","article-title":"T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.","volume":"78","author":"JM Brenchley","year":"2004","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells.","volume":"417","author":"DC Douek","year":"2002","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/593017","article-title":"Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection.","volume":"198","author":"C Geldmacher","year":"2008","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1128\/IAI.68.6.3314-3321.2000","article-title":"Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides.","volume":"68","author":"SM Arend","year":"2000","journal-title":"Infect Immun"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.micinf.2006.04.025","article-title":"A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens.","volume":"8","author":"A Grover","year":"2006","journal-title":"Microbes Infect"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.","volume":"181","author":"S Bertholet","year":"2008","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-3083.2002.01152.x","article-title":"Specific acquired resistance in mice immunized with killed mycobacteria.","volume":"56","author":"EM Agger","year":"2002","journal-title":"Scand J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T04:49:53Z","timestamp":1560401393000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022074"}},"subtitle":[],"editor":[{"given":"Clive M.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022074","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}